IRIS
MALAGNINO, VINCENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.672
AS - Asia 3.170
EU - Europa 2.529
Continente sconosciuto - Info sul continente non disponibili 490
SA - Sud America 460
AF - Africa 62
OC - Oceania 15
Totale 14.398
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.521
SG - Singapore 1.381
IT - Italia 987
CN - Cina 504
BR - Brasile 355
RU - Federazione Russa 350
HK - Hong Kong 324
VN - Vietnam 260
BD - Bangladesh 238
DE - Germania 206
IE - Irlanda 161
GB - Regno Unito 124
FI - Finlandia 117
JP - Giappone 106
SE - Svezia 106
KR - Corea 101
FR - Francia 94
NL - Olanda 89
CA - Canada 84
PL - Polonia 72
IN - India 70
ES - Italia 61
UA - Ucraina 46
AR - Argentina 39
ID - Indonesia 38
MX - Messico 38
AT - Austria 34
TR - Turchia 33
IQ - Iraq 29
CO - Colombia 22
ZA - Sudafrica 20
CZ - Repubblica Ceca 16
PH - Filippine 16
EC - Ecuador 13
JM - Giamaica 13
BE - Belgio 11
PK - Pakistan 11
VE - Venezuela 11
CH - Svizzera 10
CL - Cile 9
IL - Israele 8
LT - Lituania 8
NZ - Nuova Zelanda 8
AU - Australia 7
MA - Marocco 7
EG - Egitto 6
GR - Grecia 6
KE - Kenya 6
SA - Arabia Saudita 6
TN - Tunisia 6
TW - Taiwan 6
UZ - Uzbekistan 6
DZ - Algeria 5
JO - Giordania 5
MY - Malesia 5
NG - Nigeria 5
PY - Paraguay 5
RO - Romania 5
HR - Croazia 4
PT - Portogallo 4
AE - Emirati Arabi Uniti 3
BB - Barbados 3
HN - Honduras 3
IR - Iran 3
NP - Nepal 3
PE - Perù 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AZ - Azerbaigian 2
BH - Bahrain 2
CR - Costa Rica 2
EU - Europa 2
KG - Kirghizistan 2
LV - Lettonia 2
MK - Macedonia 2
NO - Norvegia 2
OM - Oman 2
PR - Porto Rico 2
RS - Serbia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BJ - Benin 1
CM - Camerun 1
DK - Danimarca 1
GF - Guiana Francese 1
GP - Guadalupe 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LC - Santa Lucia 1
ML - Mali 1
MT - Malta 1
Totale 13.909
Salva come PNG Salva come JPEG
Città #
Wilmington 1.356
Houston 911
Woodbridge 848
Singapore 788
San Jose 471
Ashburn 334
Hong Kong 318
Rome 316
Chandler 284
Fairfield 283
Council Bluffs 262
New York 257
Beijing 195
Los Angeles 152
Santa Clara 126
Dublin 120
Seattle 117
Ann Arbor 113
Cambridge 106
Ho Chi Minh City 103
Tokyo 103
Helsinki 87
Milan 83
The Dalles 82
Buffalo 67
Medford 67
Hanoi 64
Munich 61
Dallas 58
Moscow 48
Nuremberg 45
São Paulo 39
London 35
Lawrence 33
Lauterbourg 32
San Diego 31
Orem 30
Dearborn 29
Kraków 28
Brooklyn 27
Frankfurt am Main 27
Montreal 27
Naples 27
Toronto 26
Chicago 25
Warsaw 25
Engelhard 24
North Bergen 23
Washington 23
Jakarta 22
Mexico City 21
Chennai 20
Denver 20
Lappeenranta 20
Atlanta 19
Jacksonville 19
Stockholm 19
Amsterdam 18
Redondo Beach 17
Roebling 17
Boardman 16
Madrid 16
Colorado Springs 15
Genoa 15
San Francisco 15
Creede 14
Manchester 14
Florence 13
Phoenix 13
Seoul 13
Vienna 13
Bari 12
Ankara 11
Johannesburg 11
Palo Alto 11
St. George 11
Brussels 10
Kingston 10
Mumbai 10
Palermo 10
Poplar 10
Turin 10
Belo Horizonte 9
Brno 9
Menlo Park 9
Rio de Janeiro 9
Auckland 8
Barcelona 8
Da Nang 8
Elk Grove Village 8
Guangzhou 8
La Veta 8
Las Vegas 8
Philadelphia 8
Salt Lake City 8
Suzhou 8
Bogotá 7
Boston 7
Erbil 7
Hefei 7
Totale 9.365
Salva come PNG Salva come JPEG
Nome #
Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor 586
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 580
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 478
High rates of chronic HBV genotype E infection in a group of migrants in Italy from West Africa: Virological characteristics associated with poor immune clearance 386
NK cells of HIV-1-infected patients with poor CD4+ T-cell reconstitution despite suppressive HAART show reduced IFN-γ production and high frequency of autoreactive CD56bright cells 377
Impact of HIV-1 tropism on the emergence of non-AIDS events in HIV-infected patients receiving fully suppressive antiretroviral therapy 361
Brief report: L-selectin (CD62L) is downregulated on CD4+ and CD8+ T lymphocytes of HIV-1-infected individuals naive for ART 348
Expression and Function of NKG2D Is Impaired in CD8+ T Cells of Chronically HIV-1-Infected Patients Without ART 347
HDV can constrain HBV genetic evolution in hbsag: Implications for the identification of innovative pharmacological targets 336
Infectious disease ward admission positively influences P. jiroveci pneumonia (PjP) outcome: A retrospective analysis of 116 HIV-positive and HIV-negative immunocompromised patients 321
HBcAb seropositivity is correlated with poor HIV viremia control in an Italian cohort of HIV/HBV-coinfected patients on first-line therapy 296
Abnormal elevation of international normalized ratio in a patient during the coadministration of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide and warfarin: a case report 285
Hepatitis B virus reactivation sustained by a hepatitis B virus surface antigen immune-escape mutant isolate in a patient who was hepatitis B core antibody positive during treatment with sofosbuvir and velpatasvir for hepatitis C virus infection: A case report 255
HIV MDR is still a relevant issue despite its dramatic drop over the years 255
Tuberculosis-related hospitalizations in a low-incidence country: A retrospective analysis in two Italian infectious diseases wards 236
Virological reactivation of hepatitis B virus is a frequent event in anti-HBc-positive/HBsAg-negative HIV-infected patients switching to Tenofovir-sparing therapy as revealed by highly-sensitive HBV assays. 213
Droplet digital PCR assay as an innovative and promising highly sensitive assay to unveil residual and cryptic HBV replication in peripheral compartment 195
Highly Sensitive HBsAg, Anti-HBc and Anti HBsAg Titres in Early Diagnosis of HBV Reactivation in Anti-HBc-Positive Onco-Haematological Patients 188
Mild clinical manifestations of SARS-CoV-2 related pneumonia in two patients with multiple sclerosis under treatment with ocrelizumab 186
Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients 185
Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection 168
Cryptic HBV replicative activity is frequently revealed in anti-HBC-positive/hbsag-negative patients with HIV infection by highly sensitive molecular assays, and can be predicted by integrating classical and novel serological HBV markers 163
Long-term SARS-CoV-2 infection associated with viral dissemination in different body fluids Including bile in two patients with acute cholecystitis 159
Frequency of atypical mutations in the spike glycoprotein in SARS-CoV-2 circulating from July 2020 to July 2022 in central Italy: a refined analysis by Next Generation Sequencing 156
Temporal trend of drug-resistance and APOBEC editing in PBMC genotypic resistance tests from HIV-1 infected virologically suppressed individuals 154
B- and T-Cell Responses After SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications 147
HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015-21 145
T-cell responses to SARS-CoV-2 in Multiple Sclerosis patients treated with ocrelizumab healed from COVID-19 with absent or low anti-Spike antibody titers 145
Longitudinal Evaluation of the QuantiFERON-TB Gold Plus Assay in Hospitalized COVID-19 Patients with a First Indeterminate Result: Resolution of Inflammation and Restoration of T-Lymphocyte Counts and Interferon-Gamma Production 137
Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in {SARS}-{CoV}-2 infected patients: a single center study 136
Predictive Value of MR-proADM in the Risk Stratification and in the Adequate Care Setting of COVID-19 Patients Assessed at the Triage of the Emergency Department 135
Thymosin Alpha 1 Mitigates Cytokine Storm in Blood Cells From Coronavirus Disease 2019 Patients 133
In patients with severe COVID-19, the profound decrease in the peripheral Bblood T-cell subsets is correlated with an increase of QuantiFERON-TB Gold Plus indeterminate rates and reflecting a reduced interferon-gamma production 133
HBeAg Levels Vary across the Different Stages of HBV Infection According to the Extent of Immunological Pressure and Are Associated with Therapeutic Outcome in the Setting of Immunosuppression-Driven HBV Reactivation 131
HBV infection in HIV-driven immune suppression 128
New markers in monitoring the reactivation of hepatitis B virus infection in immunocompromised hosts 128
Persistence of circulating CD169+monocytes and HLA-DR downregulation underline the immune response impairment in PASC individuals: the potential contribution of different COVID-19 pandemic waves 125
Human Arboviral Infections in Italy: Past, Current, and Future Challenges 123
for the Icona Foundation Study Group Reactivation of hepatitis B virus is a frequent event in anti-HBc-positive/HBsAg-negative HIV-infected patients switching to Tenofovir sparing therapy as revealed by highly sensitive HBV assays. 122
Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort 121
Expression analysis of miRNA hsa-let7b-5p in naso-oropharyngeal swabs of COVID-19 patients supports its role in regulating ACE2 and DPP4 receptors 119
Validation of the T-Lymphocyte Subset Index (TLSI) as a Score to Predict Mortality in Unvaccinated Hospitalized COVID-19 Patients 114
Brain abscess caused by Actinomyces turicensis in a non-immunocompromised adult patient: a case report and systematic review of the literature 113
Molecular and Structural Aspects of Clinically Relevant Mutations of SARS-CoV-2 RNA-Dependent RNA Polymerase in Remdesivir-Treated Patients 110
Genotypic HIV-1 tropism determination might help to identify people with exhausted treatment options and advanced disease 108
Circulation of sars-cov-2 variants in central Italy: spike variability characterization by deep-sequencing. 107
Bictegravir/emtricitabine/tenofovir alafenamide ensures high rates of virological suppression maintenance despite previous resistance in PLWH who optimize treatment in clinical practice 105
Remdesivir Influence on SARS-CoV-2 RNA Viral Load Kinetics in Nasopharyngeal Swab Specimens of COVID-19 Hospitalized Patients: A Real-Life Experience 103
Prevalence of hepatitis D virus infection in Central Italy has remained stable across the last 2 decades with dominance of subgenotypes 1 and characterized by elevated viral replication 101
Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies 101
Role of HBcAb Positivity in Increase of HIV-RNA Detectability after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Months 48 Results of a Multicenter Italian Cohort 100
Ceftazidime/Avibactam-Resistant Klebsiella pneumoniae subsp. pneumoniae Isolates in a Tertiary Italian Hospital: Identification of a New Mutation of the Carbapenemase Type 3 (KPC-3) Gene Conferring Ceftazidime/Avibactam Resistance 99
The Impact of Viral and Bacterial Co-Infections and Home Antibiotic Treatment in SARS-CoV-2 Hospitalized Patients at the Policlinico Tor Vergata Hospital, Rome, Italy 98
HUMAN ENDOGENOUS RETROVIRUSES EXPRESSION CORRELATES WITH HIV RESERVOIR, LYMPHOCYTES ACTIVATION AND LOW CD4 COUNT IN VIROLOGICALLY SUPPRESSED PATIENTS 97
HIV DNA viral reservoirs in blood and gut-associated lymphoid tissues (GALT): Implications of switch from triple antiretroviral therapy (ART) to 2-drug dolutegravir/lamivudine regimens 95
An in-depth characterization of VOCs circulation by using NGS analysis of the Spike protein. 94
HDV epidemic in Central Italy is stable over the last two decades and is characterized by the circulation of multiple HDV subgenotypes 1 inducing different inflammatory stimuli 92
Predicting Factors of Plasma HIV RNA Undetectability after Switching to Co-Formulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Experienced HIV-1 Patients: A Multicenter Study 91
Hepatitis delta virus (HDV) infection : frequency and outcome in persons living with HIV (PLWH). Data from the ICONA (Italian cohort of naïve for antiretrovirals) cohort 91
HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects From the ICONA Italian Cohort of HIV-Infected Patients 91
Resistance to Ceftazidime/Avibactam in Klebsiella pneumoniae KPC-Producing Isolates: A Real-Life Observational Study 90
HDV replicative activity parallels the production of the three HBsAg forms (Large, Middle and Small HBsAg) and its pathogenetic impact is exacerbated by concomitant HBV replication 90
An In-Depth Characterization of SARS-CoV-2 Omicron Lineages and Clinical Presentation in Adult Population Distinguished by Immune Status 88
HBcAb Positivity Is a Risk Factor for an Increased Detectability of HIV RNA After Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Analysis of a Multicenter Italian Cohort 87
Latent Tuberculosis Infection in Haematopoietic Stem Cell Transplant Recipients: A Retrospective Italian Cohort Study in Tor Vergata University Hospital, Rome 85
Stable temporal trend of HDV seroprevalence in central Italy across the last two decades with the circulation of HDV sub-genotypes 1 inducing different inflammatory stimuli 83
The evolving landscape of COVID-19: Factors associated with in-hospital COVID-19 related mortality during the 2023-2024 phase of JN.1 subvariant dominance 83
Hepatitis B-related hepatic flare during immune reconstitution syndrome after antiretroviral treatment initiation in an HBV surface antigen-positive patient with HIV: viroimmunological and histological characterization 82
Determinants of worse liver-related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort 82
Kinetics of hepatitis B virus replication in anti-HBc positive/HBsAg-negative people with HIV switching to tenofovir sparing therapy 81
Long-Term Longitudinal Analysis of Neutralizing Antibody Response to Three Vaccine Doses in a Real-Life Setting of Previously SARS-CoV-2 Infected Healthcare Workers: A Model for Predicting Response to Further Vaccine Doses 81
Higher levels of three HBsAg forms (Large, Middle and Small HBsAg) are associated with HDV replication and with the degree of disease and liver damage. 81
A peculiar HBsAg isoforms composition characterizes chronic HDV coinfection respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity. 80
Real-life Data on Cefiderocol Efficacy and Safety to Treat Multidrug-Resistant Acinetobacter baumannii Infections 79
PREVALENCE AND OUTCOME OF HEPATITIS DELTA VIRUS (HDV) INFECTION AMONG PERSONS LIVING WITH HIV (PLWH) IN ITALY: THE DELTA-ICONA STUDY OC 150 79
HDV INFECTION IS STABLE IN CENTRAL ITALY ACROSS THE LAST TWO DECADES AND IS CHARACTERIZED BY THE CIRCULATION OF MULTIPLE HDV SUB-GENOTYPES 1 WITH A DIFFERENT PRO-INFLAMMATORY POTENTIAL 79
Chronic HDV coinfection (CHD) is characterized by a different HBsAg isoforms composition respect to HBV mono-infection with higher middle- and large-HBs levels paralleling the replicative and cytolytic activity of HDV. 76
Chronic HDV coinfection (CHD) is characterized by a more elevated production of Middle and Large HBsAg than HBV mono-infection, that parallels HDV replicative and cytolytic activity. 75
null 74
Drug-Induced Progressive Multifocal Leukoencephalopathy (PML): A Systematic Review and Meta-Analysis 73
HBcAb Positivity as a Risk Factor for Missing HIV RNA Undetectability after the 3TC+DTG Switch 70
PATHWAYS UNDERLYING HDV PERSISTENCE ACT INDEPENDENTLY FROM THE EXTENT OF HBV RESEVOIR AND ARE SUSTAINED BY AN ABUNDANT PRODUCTION OF HBSAG DERIVED FROM INTEGRATED HBV-DNA P 214 70
The intrahepatic activity of Hepatitis Delta virus is sustained by an abundant production of HBs transcripts, mainly derived from integrated HBV-DNA, and is not strictly related to the extent of HBV reservoir 69
Total HIV DNA and cell-associated HIV RNA viral reservoirs in PBMCs and GALT in patients on triple-ART and switching to dual-ART regimens. 68
The transactivation of endogenous retroviruses correlates with HIV reservoir, lymphocytes activation and low CD4 count in virologically suppressed patients 64
Chronic HDV infection is sustained by an intense HBsAg production fromintegrated HBVDNA in the setting of a limited or even absent HBV reservoir. 64
Occult Hepatitis B Virus Infection: An Old Entity With Novel Clinical Involvements 63
New insights into hepatitis B virus lymphotropism: implications for HBV-related lymphomagenesis 62
Chronic HDV coinfection is characterized by a peculiar HBsAg isoforms composition respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity. 61
The transactivation of human endogenous retroviruses is associated with HIV-1 reservoir, lymphocyte activation and low CD4 count in virologically suppressed PLWH 61
HBsAg production from integrated HBV-DNA sustains HDV persistence in the setting of a limited or even absent HBV reservoir 59
Association between markers of hepatitis B virus infection and risk of virological rebound in people with HIV receiving antiretroviral therapy 57
HDV persistence is sustained by HBsAg mainly derived from integrated HBV-DNA and is independent from the extent of HBV reservoir 57
Pathways sustaining HDV activity act independently from the size of HBV resevoir and are fueled by an abundant expression of HBsAg from integrated HBV-DNA 57
Infezione da virus dell’epatite B correlati con l’infezione da Virus dell’Immunodeficienza Umana (HIV) 51
COVID ‐19 and Liver Injury, Beyond the First Pandemic Waves: Clinical and Immune‐Virological Features 50
Daptomycin-Induced Eosinophilic Pneumonia: A Case Report and Systematic Review 47
Poor CD4/CD8 ratio recovery in HBcAb-positive HIV patients with worse immune status is associated with significantly higher CD8 cell numbers 44
Hepatitis B virus genotype G and liver fibrosis progression in chronic hepatitis B and human immunodeficiency virus coinfection 40
COVID-19 and influenza vaccination among adults stably engaged in HIV care 39
Totale 14.013
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.350
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.350
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022541 0 50 27 41 4 60 28 60 115 41 18 97
2022/2023908 72 69 158 95 75 159 73 73 58 4 44 28
2023/2024671 74 19 62 52 30 111 39 31 29 107 33 84
2024/20252.439 78 378 242 170 101 190 270 141 260 201 211 197
2025/20265.106 473 201 411 453 436 224 676 551 620 426 339 296
2026/2027599 350 249 0 0 0 0 0 0 0 0 0 0
Totale 14.398